Three central regions were defined in both pre- and on-treatment sections: cancer, fibroblasts, and TF areas, consisting primarily of immune cells and cancer cells, with fewer cancer cells and more normal epithelial cells in the on-treatment sections (Figs. 2a, S4a). This evidence concerns the gene TF and cancer.